NSW Introduces Needle-Free Flu Vaccine for Young Children
The New South Wales government has announced the availability of needle-free flu vaccines for children across the state, following the worst flu season on record. This initiative targets kids aged two to four, offering free nasal spray vaccines to encourage higher vaccination rates as parental trust in vaccine efficacy declines.
Addressing Fear of Needles
According to Dr Rebekah Hoffman, Chair of the Royal Australian College of GPs NSW/ACT, approximately two-thirds of children and a quarter of adults experience a strong fear of needles. The new nasal spray vaccine, known as FluMist, is described by the NSW government as "gentle, painless, and needle-free", administered with one spray into each nostril. This alternative aims to alleviate anxiety for both parents and children during vaccination.
Availability and Safety
FluMist is already free in Queensland and South Australia for children aged two to five, and in Western Australia for those aged two to twelve. The vaccine has been used safely since 2003, with millions of doses administered in countries like the United Kingdom, Europe, the United States, and Canada, according to SA Health. Mild side effects may include a runny or blocked nose, headache, or general tiredness, while serious reactions such as persistent high fever or allergic responses are rare.
Response to Rising Flu Cases
The rollout comes after more than 24,500 influenza cases were recorded in children under five during NSW's extended flu season last year. In 2025, children under five with flu-like illnesses presented to emergency departments 4,600 times, with an additional 960 hospital admissions. This represents a 40 per cent increase in both presentations and admissions compared to 2024. The spray vaccine will be accessible through GPs, Aboriginal Medical Services, and community pharmacies under the NSW Nasal Spray Influenza Vaccination Program.
Parental Perceptions and Barriers
A 2025 survey by the National Vaccination Insights project, involving 2,012 parents of children under five, found that 72 per cent would be more likely to vaccinate their child with a needle-free option. However, the study also revealed waning confidence in vaccines, with 22 per cent of parents doubting the flu vaccine's effectiveness, up from 12 per cent the previous year. Dr Maryke Steffens from the National Centre for Immunisation Research and Surveillance noted that influenza vaccination is increasingly deprioritised due to perceptions of low disease risk and poor vaccine effectiveness, alongside access issues like cost and appointment availability.
Cost-of-living concerns and barriers such as travel expenses, time off work, and language difficulties continue to hinder vaccine uptake, particularly among financially stressed families, those in regional areas, and non-English speakers. Dr Jess Kaufman of the Murdoch Children's Research Institute highlighted that even funded vaccines can involve indirect costs.
Broader Flu Context
NSW recorded its highest number of influenza cases across all age groups in 2025, with 186,768 notifications—a 15.8 per cent increase from 2024 and a 79 per cent jump from 2023. Dr Nic Woods, Bupa's chief medical officer, warned that Australia saw the highest flu deaths since the Spanish flu pandemic over a century ago, citing a strain called "Super K" that dominated the northern hemisphere winter and spreads rapidly.
Injectable flu vaccines remain free for children under five, adults over 65, pregnant women, Aboriginal people, and those with serious health conditions under the National Immunisation Program in 2026. NSW Health Minister Park urged residents to get vaccinated, stating, "The influenza vaccine is the best chance of protection against serious illness", and recommended using out-of-hospital care options for non-emergencies to ease pressure on emergency departments.
